A major shift is happening in the world of genetic data. Regeneron, a big name in biotechnology, is stepping in to buy 23andMe, a company known for its DNA testing kits. The price tag? A cool $256 million. This move comes as 23andMe faces bankruptcy, but Regeneron has plans to keep the company running smoothly. They want to honor the privacy promises made to 23andMe'...

The company 23andMe is in a tough spot. It is struggling financially and dealing with a major data breach. This has raised serious questions about the future of the genetic data of its 15 million customers. The firm, once a leader in DNA testing, is now facing an uncertain future. Its value has dropped drastically since it went public in 2021. The company has never m...

You've sent your saliva to 23andMe for genetic testing, but what happens if the company runs into trouble? Recently, 23andMe announced they're letting go of 40% of their staff. After their board resigned last year, the company's stock nosedived, raising doubts about its future. CEO Anne Wojcicki says she wants to take the company private, but customers are worried ab...